Hutch News

Hutch News

Stories tagged 'Pancreatic Cancer'

Dr. Sita Kugel named 2018 V Scholar

Pancreatic cancer researcher will focus on development of targeted therapeutics

Nov. 20, 2018 | By Sabrina Richards / Fred Hutch News Service

Fred Hutchinson Cancer Research Center pancreatic cancer researcher Dr. Sita Kugel has been named a 2018 V Scholar by the V Foundation for Cancer Research. The two-year, $200,000 award will support Kugel’s goal of developing a targeted therapy for an aggressive subtype of pancreatic cancer.

View story >


5 questions with a cancer immunotherapy expert

Dr. Phil Greenberg to receive high honor for his contributions to the field

Nov. 7, 2018 | By Susan Keown / Fred Hutch News Service

Immune-harnessing treatments are revolutionizing cancer care. Where is the immunotherapy field now, and what's next? Fred Hutch science writer Susan Keown asked someone who would know: Dr. Phil Greenberg.

View story >


Lyani Valle: Leukemia survivor, Obliteride walker

'Cancer was a huge wake-up call to what is important in life'

Aug. 3, 2018 | By Sabin Russell / Fred Hutch News Service

Obliteride walker Lyani Valle, a program manager at Amazon, survived a rare form of leukemia using a therapy made possible by Fred Hutch research.

View story >


Immunotherapy strategy for ovarian cancer aims to rewire a ‘kill switch’ to ramp-up signal

T cells bearing a new engineered protein boost immunotherapy’s effectiveness in laboratory models of AML, ovarian, pancreatic cancers

April 16, 2018 | By Rachel Tompa / Fred Hutch News Service

In an effort to improve the efficacy of immunotherapy for solid tumors, Fred Hutch researchers have engineered a new type of protein that can rewire a 'kill switch' to stimulate T cells' activity instead.

View story >


Dr. Sita Kugel receives $100K grant to study pancreatic neuroendocrine tumors

She will use preclinical models to study the role of DNA packaging in cancer development and metastasis

March 29, 2018 | By Sabrina Richards / Fred Hutch News Service

View story >


Experimental drug makes some pancreatic cancers more vulnerable to chemo

Early trial shows possibility of knocking down a ‘daunting’ cancer’s defense

Dec. 12, 2017 | by Susan Keown / Fred Hutch News Service

An experimental drug that helps chemo penetrate pancreatic tumors lengthened progression-free survival in a Phase 2 trial.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.